Changes in craving for a cigarette and arterial nicotine plasma concentrations in abstinent smokers

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 4, 2004, Pages 617-623

  Guthrie, Sally K ^a,b   Ni, Lisong ^c   Zubieta, Jon Kar ^a,b,d   Teter, Christian J ^a   Domino, Edward F ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Abstinent smokers; AN; AN 1; AN 2; AUC; average nicotine cigarette; Cigarette; Craving; first average nicotine cigarette; Nicotine; Pharmacokinetics; second average nicotine cigarette; Tobacco smoke

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CALCULATION; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENERAL ASPECTS OF DISEASE; HUMAN; LEISURE; MALE; MANIPULATIVE MEDICINE; MEASUREMENT; NERVOUSNESS; SAMPLE; SMOKING CESSATION; TOBACCO; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AFFECT; AREA UNDER CURVE; CUES; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; SMOKING; SMOKING CESSATION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 3342973835     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.01.005     Document Type: Article

References (21)

1. Benowitz N.L., Jacob P. Intravenous nicotine replacement suppresses nicotine intake from cigarette smoking. J. Pharmacol. Exp. Ther. 254:1990;1000-1005
2. Benowitz N.L., Jacob P., Jones R.T., Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J. Pharmacol. Exp. Ther. 221:1982;368-372
3. Bergen A.W., Caporaso N. Cigarette smoking. J. Natl. Cancer Inst. 91:1999;1365-1375
4. Brauer L.H., Behm F.M., Lane J.D., Westman E.C., Perkins C., Rose J.E. Individual differences in smoking reward from de-nicotinized cigarettes. Nicotine Tob. Res. 3:2001;101-109
5. Buchhalter A.R., Schrinel L., Eissenberg T. Withdrawal suppressing effects of a novel smoking system: comparison with own brand, not own brand, and denicotinized cigarettes. Nicotine Tob. Res. 3:2001;111-118
6. Fattinger K., Verotta D., Benowitz N.L. Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans. J. Pharmacol. Exp. Ther. 281:1997;1238-1246
7. First, M.B., Spitzer, R.I., Gibbon, M., Williams, J., 1996. Structured Clinical Interview for DSM-IV Axis I Disorders. Biometrics Research, New York State Psychiatric Institute.
8. Gourlay S.G., Benowitz N.L. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clin. Pharmacol. Ther. 62:1997;453-463
9. Guthrie S.K., Zubieta J.-K., Ohl L., Ni L., Koeppe R.A., Minoshima S., Domino E.F. Arterial/venous plasma nicotine concentrations following nicotine nasal spray. Eur. J. Clin. Pharmacol. 55:1999;639-643
10. Hariharan M., VanNoord T., Greden J.F. A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. Clin. Chem. 34:1988;724-729
11. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.-O. The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br. J. Addict. 86:1991;1119-1127
12. Jarvik M.E., Madsen D.C., Olmstead R.E., Iwamoto-Schaap P.N., Elins J.L., Benowitz N.L. Nicotine blood levels and subjective craving for cigarettes. Pharmacol. Biochem. Behav. 66:2000;553-558
13. Kadoya C., Domino E.F., Matsuoka S. Relationship of electroencephalographic and cardiovascular changes to plasma nicotine levels in tobacco smokers. Clin. Pharmacol. Ther. 55:1994;370-377
14. Lucchesi B.R., Schuster C.R., Emley G.S. The role of nicotine as a determinant of cigarette smoking frequency in man with observations of certain cardiovascular effects associated with tobacco alkaloid. Clin. Pharmacol. Ther. 8:1967;789-796
15. Porchet H.C., Benowitz N.L., Sheiner L.B. Pharmacodynamic model of tolerance: application to nicotine. J. Pharmacol. Exp. Ther. 244:1988;231-236
16. Robinson J.H., Pritchard W.S., Davis R.A. Psychopharmacological effects of smoking a cigarette with typical "tar" and carbon monoxide yields but minimal nicotine. Psychopharmacology. 108:1992;466-472
17. Rose J.E., Behm F.M., Westman E.C., Johnson M. Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacol. Biochem. Behav. 67:2000;71-81
18. SAS, 1996. Version 6.12. SAS Institute, Cary, NC, USA.
19. Schuh K.J., Stitzer M.L. Desire to smoke during spaced smoking intervals. Psychopharmacology. 120:1995;289-295
20. USDHHS, 1988. The Health Consequences of Smoking: A Report of the Surgeon General. Rockville: Public Health Service.
21. Xu X., Domino E.F. Effects of tobacco smoking on topographic EEG and Stroop test in smoking deprived smokers. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 24:2000;535-546